FAM
CHRS icon

Fred Alger Management’s Coherus Oncology CHRS Stock Holding History

Fred Alger Management’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-177,391
Closed -$2.29M – 513
2022
Q1 		$2.29M Sell
177,391
-258,797
-59% -$3.29M 0.01% 333
2021
Q4 		$6.96M Buy
436,188
+3,754
+0.9% +$65.6K 0.02% 263
2021
Q3 		$6.95M Buy
+432,434
New +$6.34M 0.02% 267
2015
Q3 		– Sell
-25,000
Closed -$723K – 475
2015
Q2 		$723K Buy
+25,000
New +$632K ﹤0.01% 445

Other funds holding CHRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Fred Alger Management's CHRS Position: Q2 2022 in Review

Fred Alger Management sold out of Coherus Oncology (CHRS) in Q2 2022, closing a stake of 177,391 shares — an estimated $2.29M sold.

Fred Alger Management first reported a position in CHRS in Q2 2015 and held it in 4 quarters. The position peaked at $6.96M in Q4 2021. 176 funds tracked by Wall St. Rank hold CHRS as of Q2 2022.

  • Fred Alger Management reported no remaining Coherus Oncology position as of Q2 2022 after selling out during the quarter.
  • Fred Alger Management sold 177,391 Coherus Oncology shares in Q2 2022, an estimated $2.29M.
  • Fred Alger Management first reported a position in Coherus Oncology in Q2 2015 and held it in 4 quarters.
  • Fred Alger Management's Coherus Oncology position peaked at $6.96M in Q4 2021.
  • 176 funds tracked by Wall St. Rank held Coherus Oncology as of Q2 2022.

Based on Fred Alger Management's 13F filing for Q2 2022, filed 15 Aug 2022.